MyOr
Preventive Healthcare for Children
Startup A Health Tech & Life Sciences Est. 2018
Total Raised
$5.5M
A
Last Round
$5M
2 rounds
Investors
6
6 public
Team
3
11-50 employees
Confidence
100/100
News
8
articles
Patents
1
About
MyOr provides noninvasive monitoring technologies that use data-driven artificial intelligence to predict and prevent chronic conditions. The company has developed a cutting-edge AI-driven platform designed to predict and mitigate the risk of food allergies, eczema, and related conditions. With a dedicated team of licensed dietitian nutritionists and innovative technologies, MyOr promotes evidence-based practices and nutrition strategies that can prevent many chronic conditions. The company is committed to improving health outcomes and empowering healthcare providers and caregivers with personalized solutions to eliminate preventable conditions, creating a healthier future for our clients.
Classification
Sector
Health Tech & Life SciencesDigital HealthcarePatient EngagementMedical Decision Support
Core Technology
Artificial IntelligenceMachine Learning
Target Customer
Financial ServicesFinancial ProductsInsuranceConsumersDemographics & FamilyChildrenHealthcare & Life SciencesHealthcareProviders
Business Model
B2CB2B2C
Tags
medical-devicesdigital-healthcareartificial-intelligencepersonalizationnutritionskin-caremachine-learningdigital-therapeuticsinsurance-companiespediatricschildrendermatologypharma-companiesbabiesactionable-insightspersonalized-medicinenon-invasivehealthcare-providerspredictive-analyticsimage-processingmonitoringpersonalized-treatment
Funding & Events
Aug 2022
A Round $5M
Arancia International, Mercantile Partners, Nesher, Polaris Partners, Irlk Ventures
Apr 2018
Seed $500K
ILRK Ventures, Arancia International
News (8)
Oct 31, 2023 · www.einpresswire.com
growth-positive
MyOr Diagnostics Brings Together a Network of Nutrition Experts to Educate Parents on Food Allergy Nutrition Strategies
Expand
Oct 25, 2023 · www.einpresswire.com
Growth-Positive
MyOr Diagnostics Wins Prestigious BNEW Prize for Best New Health Startup
CustomersPartnersInvestment
Jun 15, 2022 · yidinfo.net
growth-positive
Israeli Baby Formula Company Seeks US Approval To Ease Shortage - Yid Info
CustomersExpand
Jun 12, 2022 · www.i24news.tv
Israeli tech company aims to solve US baby formula crisis - I24NEWS
Aug 11, 2021 · www.israel21c.org
growth-positive
This startup aims to predict and prevent allergies in babies
Customers
Jun 28, 2021 · www.prnewswire.com
growth-positive
MYOR to Launch NURTURE Precision Infant Care™ - Early Intervention Platform for Tackling Childhood Allergies
Customers
Oct 15, 2020 · jlm-biocity.org
growth-positive
MYOR Begins US Commercialization of its Breakthrough Platform to Prevent Allergic Conditions - JLM-BioCity
CustomersInvestment
Feb 17, 2020 · www.5-ht.com
https://www.5-ht.com/en/2020/02/17/what-our-skin-tells-us-about-our-body/
Details
Product Stage
Released
Employees
11-50
Exact Count
39
District
Center District
Founded
2018
Registrar
515811206
Crunchbase
myor-diagnostics
Locations
Bareket Street 29, Zikhron Ya'akov, Israel
Links
Website
LinkedIn
Facebook
Careers
Admin
Last Update
Mar 19, 2025
Verified by
Yotam Maman
Claimed
Yes
Missing
markets
Team (3)
Dr. Ariel Katz
Co-founder & Chairman
Founder
Michael Brandwein
Co-founder & VP R&D
Founder
Esther Levenson
Head of Global Scientific Communications
Internal
Created by
Yotam Maman (yotamm1988@gmail.com)
Created
2018-10-02T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)